A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects

NCT06563713 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Oligozoospermia
Asthenozoospermia

Interventions

DRUG: STSP-0902 injection
DRUG: Placebo

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd